Alliance Pharma shares hit a new record high after morning sickness drug breakthrough
Shares in Alliance Pharma (APH:AIM) have soared to a new record high of 95.2p after having morning sickness drug Diclectin approved by a regulator.The Medicine and Healthcare Products Regulatory Agency (MHRA) has given the green...
07 June 2018